A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

There's a growing body of evidence that gold nanoparticles can offer significant, targeted weight loss that focuses on fat ...

Utah has one of the nation's lowest rates of prescriptions for anti-obesity GLP-1 drugs like Wegovy and Ozempic — but their ...

A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

That support doesn't go for teens. More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

The number of prescriptions for anti-obesity GLP-1 drugs like Wegovy and Ozempic is rising in North Carolina, just as it is nationwide — a trend that could have substantial effects on a range of ...

When it comes to ages 12 to 18 who are dealing with obesity, Americans are divided: About one-third say the use of weight-loss drugs in this context is a "very" or "somewhat" good thing, a similar ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health ...

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a survey published Friday. The new Associated Press (AP)-NORC ...

Obesity-drug maker Metsera Inc.’s stock jumped 47% on Friday as the biggest gainer among three initial public offerings bucking a swoon in the equity market to rise in their stock-market debuts ...